Semler Scientific, Inc. Overview
Pro stress-test →Semler Scientific is a dual-focused healthcare technology company providing QuantaFlo, an FDA-cleared point-of-care blood flow diagnostic device for vascular disease detection, while simultaneously operating a significant corporate Bitcoin treasury strategy. The company serves cardiologists, nephrologists, and other healthcare providers across the US, while also positioning itself as a leading corporate holder of Bitcoin as a treasury reserve asset.
Strategic Profile
Pro stress-test →The company has bifurcated its strategy into two distinct businesses: its core QuantaFlo medical device business targeting peripheral artery disease detection, and CardioVanta, a newly formed SaaS subsidiary focused on heart failure detection. This dual approach allows Semler to maintain healthcare technology leadership while leveraging Bitcoin holdings as a strategic financial hedge against inflation and currency devaluation, distinguishing it from traditional medical device companies.
Competitive Landscape
Pro stress-test →In medical diagnostics, Semler competes with traditional vascular imaging companies and point-of-care diagnostic providers serving cardiology and vascular specialists. In the corporate Bitcoin space, Semler positions itself alongside MicroStrategy and other public company Bitcoin treasuries. The company's unique dual positioning creates limited direct competitors, though it faces competitive pressure from both established medical device firms and emerging SaaS healthcare platforms.
Industry Context
Semler Scientific, Inc. operates in Medical Device Manufacturing / Healthcare Technology / Corporate Digital Asset Treasury.
Key facts
Founded: 2007 · Headquarters: Santa Clara, California · Revenue: $56.3M (2024)